Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

June 1, 2024

Study Completion Date

June 1, 2024

Conditions
Upper Gastrointestinal Bleeding
Interventions
DRUG

Metoclopramide

Patients will receive metoclopramide 20 mg IV in a single dose prior to randomization.

DRUG

Placebo

Patients will receive placebo 10 ml IV in a single dose prior to randomization.

Trial Locations (1)

64460

Hospital Universitario Dr. José Eleuterio González, UANL, Monterrey

All Listed Sponsors
lead

Universidad Autonoma de Nuevo Leon

OTHER